INTRODUCTION
In the central and peripheral nervous systems, prostaglandin (PG) F 2α plays unique roles in various physiological and pharmacological activities such as pain transmission (allodynia) in the spinal cord of conscious mice (1) and induction of depolarization in the postsynaptic actions of cerebellar Purkinje cell dendrites (2) .
These actions of PGF 2α are controlled by its synthesis and binding site. PGF 2α is synthesized by PGF synthase (PGFS) (EC 1.1.1.188) and binds to a specific receptor, FP.
PGFS exists as three isozymes: PGFS I (formerly lung-type PGFS), PGFS II
(formerly liver-type PGFS) (3, 4) , and prostamide/prostaglandin F synthase (5) . The first two isozymes, PGFS I and PGFS II, belong to the aldo-keto reductase superfamily based their on substrate specificity, molecular weight (~37 kDa), and amino acid sequences. In arachidonate metabolism, PGFS I and PGFS II catalyze two reductions of PGH 2 to PGF 2α and PGD 2 to 9α,11β-PGF 2 . PGH 2 is synthesized from arachidonate by cyclooxygenase (COX), and PGD 2 is synthesized from PGH 2 by PGD synthase. The isozymes have different K m values for PGD 2 , i.e., 120 µM for PGFS I and 10 µM for PGFS II. Prostamide/prostaglandin F synthase was identified recently as a new type of the enzyme that belongs to the thioredoxin-like superfamily (5) . Prostamide/prostaglandin F synthase catalyzes both the reduction of prostamide H 2 to prostamide F 2α and that of PGH 2 to PGF 2α . However PGD 2 does not serve as a substrate for the synthase.
PGF 2α is one of the major prostanoids produced in the rat central nervous system, including the spinal cord (6) , where PGF synthase activity is also detected (7) . We have reported on the existence and localization of PGFS I and PGFS II in the rat by guest, on www.jlr.org Downloaded from 5 spinal cord. Our previous immunocytochemical study of PGFS I in the rat spinal cord showed that the immunoreactivity was distributed widely in the gray substance and was especially strong in neuronal dendrites in laminae I and II of the dorsal horn, and in lamina IX of the ventral horn (8) . In contrast, PGFS II was not found in the neuronal elements and but was found in ependymal cells and tanycytes surrounding the central canal (9) . Both enzymes were found in endothelial cells of blood vessels in the rat spinal cord. To clarify the biological relevance of the distinct localization of PGFS I and PGFS II, the binding site of PGF 2α (i.e., localization of the PGF 2α receptor, FP) must be identified. FP transduces the PGF 2α signal by coupling with the G q protein (10) . In FP-deficient mice, the targeted allele is expressed highly in the corpus luteum of the ovary and in the distal tubules of the kidney (11, 12) . However, no one has reported on the morphological analysis of FP in the central nervous system.
In the present study, we demonstrate the localization of FP in the rat spinal cord using a specific antibody. 
MATERIALS AND METHODS

Animals and anesthesia
Twelve male and 12 female specific pathogen-free Wistar rats (6-8 weeks old, weighing 150-180 g; provided by Japan SLC Inc., Shizuoka, Japan), 2 male FPdeficient mice (11) , and 2 male C57BL/6 mice (SLC, Inc.) (9 weeks old, weighing 23-27 g) were used in the present study. The animals were anesthetized deeply with sodium pentobarbital (100 mg/kg of body weight) before the subsequent procedures. 
Western blot analysis
Spinal cords from male and female rats and the uteri were homogenized in a lysis buffer containing 25 mM Tris (pH 8.0), 1 mM EDTA, 0.5 mM DTT, 10 mM MgCl 2 , 1% protein inhibitor cocktail (Sigma Chemical Co., St Louis, MO), and 0.25 M sucrose, and centrifuged at 800 × g for 15 min at 4°C. The homogenate was centrifuged at 100,000 × g for 1 h at 4°C, the supernatant was removed, and the expression of FP was measured in the precipitate. The protein concentration of each fraction was measured using a BCA protein assay reagent kit (Pierce, Rockford, IL).
Forty micrograms of each precipitate fraction was subjected to electrophoresis in a 10-20% SDS-polyacrylamide gel (Daiichi Pure Chemicals Co. Ltd., Tokyo, Japan). The sections were analyzed using CLSM, (Radiance 2000, Bio-Rad Laboratories, Inc., Hercules, CA) on the light microscope (Nikon Eclipse E800) at 488 nm and 568 nm wavelengths for excitation with the appropriate filter sets. These immunocytochemical procedures generally followed those in our previous studies (8, 9) . 
RESULTS
Expression of FP in rat spinal cord
Expression of FP in the rat spinal cord was investigated by Western blot analysis (Fig. 1) . The single protein band of FP (~64 kDa) was detected in rat spinal cord and uterus as a positive marker. The protein band was not detected with the antigenabsorbed anti-IgG.
Localization of FP in the rat spinal cord
To examine the distribution of FP in the rat spinal cord, transverse sections were subjected to single immunostaining (Fig. 2) . FP immunoreactivity was distributed diffusely in the gray substance of the rat spinal cord and was especially intense in laminae I, II, and IX. The immunoreactivity was similar to the distribution of PGFS I shown in our previous report (8) .
At higher magnification (Fig. 3) , immunoreactivity was found in the neuronal somata and dendrites at all segmental levels. However, it was not found in the vascular endothelium in the whole spinal cord or in the ependymal layer surrounding the central canal in lamina X. The immunoreactivity was stronger in dendrites than in the somata. The immunoreactivity of FP in the somata and dendrites was similar to that of PGFS I (8). Some colored dots in the white substance (Fig. 3A) were also observed in the section treated with antigen-absorbed anti-FP IgG (Fig. 3E) , and we consider this to indicate a nonspecific reaction. No immunoreactivity was observed in the gray matter of the control sections (Fig. 3F) . To confirm the specificity of anti-FP IgG, the immunohistochemistry was carried out in C57BL/6 and FP-deficient mice spinal cords (Fig. 4) . The intense immunoreactivity was found in gray substance of (Fig. 5) , which showed that the same neuronal somata and dendrites were immunostained by both of the antidobies.
Multiple immunofluorescent staining
We performed double immunostaining with anti-FP and anti-MAP2 antibodies to confirm the immunoreactive elements in the neuronal somata and dendrites. CLSM images indicated that all FP-immunoreactive cells were also immunoreactive for MAP2 (Fig. 6) . The colocalization pattern of FP and MAP2 was similar to that of PGFS I and MAP2 (8) , suggesting that FP colocalizes with PGFS I in the rat spinal cord. The fluorescence intensity of MAP2 was relatively homogeneous in the whole region of the gray substance but that of FP was higher in laminae I and II of the dorsal horn. In additional multiple staining, FP colocalized with MAP2 but not with tomato lectin, a marker of endothelial cells (Fig. 6C) . In the ependymal cells and tanycytes, FP did not colocalize with vimentin (Fig. 6D) . constitutively in the rat hippocampus, and its expression is upregulated by kainic acid, which induces seizure. Kainic acid treatment stimulates the production of large amounts of PGF 2α , and this production is inhibited by the selective COX-2 inhibitor, NS398 (16) . This suggests that the PGF 2α synthetic pathway through COX-2 and PGFS I is present and that PGF 2α acts in an autocrine fashion in some region of brain.
Previous studies demonstrate that specific inhibitors of COX-2, SC236, and celecoxib decrease the production of prostaglandins, proinflammatory cytokines, reactive oxygen species, and free radicals, and so significant protection against the loss of spinal motor neurons in amyotrophic lateral sclerosis (ALS) (17, 18) . These studies implicate the prostaglandins produced by COX-2 as a mediator of both excitotoxic and inflammatory processes, which cause motor neuron death. COX-2 by guest, on www.jlr.org Downloaded from activity contributes to neuronal toxicity in hippocampal and cerebral ischemia (19, 20) . Increased COX-2 activity may also contribute to neuronal death in the neuronal degeneration of Parkinson's (21, 22 ) and Alzheimer's (23) diseases. It is unclear which prostaglandin produced by COX-2 is a trigger of neuronal death.
Administration of PGF 2α into the spinal cord causes significant cell loss and increases the extracellular levels of hydroxyl radicals and malondialdehyde, an end product of membrane lipid peroxidation (24) . The concentration of PGF 2α measured by microdialysis sampling increases immediately in experimental impact injury to the rat spinal cord. On the other hand, another major prostaglandin, PGE 2 , paradoxically protects motor neurons in the model of ALS (25) and cerebral ischemia (26, 27) .
Activation of the isoforms of the PGE 2 -specific receptors EP1-EP4, EP2, and EP3 protect motor neurons in the spinal cord, and EP2 does the same in hippocampal neurons. Thus, the balance between PGE 2 and PGF 2α production and activation of the specific receptors might be involved in neuronal plasticity. 
